Physician

Ali Imran Amjad, M.D.

According to 2025 Medicare claims, Ali Amjad, M.D. (NPI: 1568690287) practices hematology/oncology, with the plurality of this provider's patient population coming from Mercer, PA. This provider's primary affiliated billing organization is ALLEGHENY CLINIC MEDICAL ONCOLOGY (NPI: 1831143403; TIN: 113683376) and primary practice location at 16105-1100. Amjad is affiliated with the ACO West Virginia (ACO ID: A3563), participating under the MSSP model.

Amjad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 484 traditional Medicare patients, billed 1,557 HCPCS/CPT codes, and received $102,015 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,644 prescription claims across 434 beneficiaries totaling $3,415,784 in drug costs, led by Erleada (Apalutamide). DME data shows 24 claims. Open Payments data shows 83 records totaling $100,142. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $13,624 and ending at $102,015. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $26,768 to $3,415,784. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $946 and ending at $2,998.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$420K$841K2015 Medicare payment: $13,624 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $405,861 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $763,662 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $648,423 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $514,376 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $498,245 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $544,977 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $840,735 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $518,653 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $102,015 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201547351$13,624
201620723,660$405,861
201735347,406$763,662
201831952,420$648,423
201926228,850$514,376
202023635,660$498,245
202131825,359$544,977
202234434,964$840,735
202346519,705$518,653
20244841,557$102,015

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.7M$3.4M2015 Drug cost: $26,768 (USD; Tot_Drug_Cst)2016 Drug cost: $229,291 (USD; Tot_Drug_Cst)2017 Drug cost: $459,489 (USD; Tot_Drug_Cst)2018 Drug cost: $778,792 (USD; Tot_Drug_Cst)2019 Drug cost: $1,069,366 (USD; Tot_Drug_Cst)2020 Drug cost: $1,536,415 (USD; Tot_Drug_Cst)2021 Drug cost: $1,565,168 (USD; Tot_Drug_Cst)2022 Drug cost: $1,545,676 (USD; Tot_Drug_Cst)2023 Drug cost: $3,044,164 (USD; Tot_Drug_Cst)2024 Drug cost: $3,415,784 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152567$26,768
201665283$229,291
2017108482$459,489
2018136717$778,792
2019141882$1,069,366
20201511,068$1,536,415
20211881,060$1,565,168
20222321,172$1,545,676
20233322,056$3,044,164
20244342,644$3,415,784

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.2K$6.3K2016 Medicare payment: $703 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $1,272 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $670 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $913 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $3,288 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $6,332 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $990 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R36$703
2017N/R68$1,272
2018N/RN/RN/R
2019N/R30$670
2020N/R22$913
2021N/R61$3,288
2022N/RN/RN/R
2023N/R101$6,332
2024N/R24$990

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more80135$112
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more338791$69
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes7491$60
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5471$47
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's150262$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ErleadaApalutamide31990$477,225
ImbruvicaIbrutinib22616$346,907
TagrissoOsimertinib Mesylate19570$333,311
EliquisApixaban27414,921$279,406
JakafiRuxolitinib Phosphate21630$262,870

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R12$811
E0431Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubingYN/R12$179

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$310Inari Medical, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.74$99,833BeiGene, Ltd.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ali Imran Amjad, M.D.?

Tedicare shows public-source Medicare data for Ali Imran Amjad, M.D. (NPI 1568690287), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Imran Amjad, M.D. have ACO affiliation data?

Ali Imran Amjad, M.D. is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563).

What billing organization is linked to Ali Imran Amjad, M.D.?

Ali Imran Amjad, M.D. is linked to ALLEGHENY CLINIC MEDICAL ONCOLOGY (billing NPI 1831143403) in the available physician profile data.

Does Ali Imran Amjad, M.D. have Open Payments data?

Ali Imran Amjad, M.D. has 83 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.